1-4 of 4
Roger von Moos, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter Phase II Trial of Bendamustine, Lenalidomide and Dexamethasone (BRd) As 2 nd -Line Therapy for Multiple Myeloma

Ulrich JM Mey, Wolfram Brugger, MD, Mario Bargetzi, Heike Schwarb, MD, Andreas Schwarzer, MD, Tobias Dechow, MD, Paul Jehner, MD, Jacqueline Rauh, MD, Christian J. Taverna, MD, Mathias Schmid, MD, Martin Schmidt-Hieber, MD, Steffen Doerfel, Natalie Fischer, MD, Axel Ruefer, MD, Carsten Ziske, MD, Wolfgang Knauf, MD, Arnd Nusch, MD, Richard Cathomas, MD, Roger von Moos, MD, Elke Hiendlmeyer, Felicitas Hitz, MD, Christoph Driessen, MD
Journal: Blood
Blood (2014) 124 (21): 4779.
https://doi.org/10.1182/blood.V124.21.4779.4779
Published: 2014
Journal Articles

SAKK 65/08: A Phase I Dose Escalation Study of Bortezomib in Combination with Nelfinavir in Patients with Advanced Hematologic Malignancies

Christoph Driessen, MD, Jürgen Bader, Marianne Kraus, PhD, Markus Jörger, MD PhD, Hilde Rosing, PhD, Gregoire Berthod, MD, Felicitas Hitz, MD, Catherine Berset, PhD, Alexandros Xyrafas, Hanne Hawle, MD, Hermann S Overkleeft, PhD, Christiana Sessa, MD, Alwin Huitema, PhD, Ulrich JM Mey, Thomas Pabst, MD, Roger von Moos, MD, Dagmar Hess, MD
Journal: Blood
Blood (2014) 124 (21): 4747.
https://doi.org/10.1182/blood.V124.21.4747.4747
Published: 2014
Journal Articles

SAKK 65/08: A Phase I Trial of the HIV Protease Inhibitor Nelfinavir in Combination with Bortezomib Identifies Nelfinavir As FDA Approved, Oral Drug that Inhibits the Proteasome and Induces Proteotoxic Stress in Vivo and has Potential Antimyeloma Activity.

Christoph Driessen, MD, Dagmar Hess, MD, Thomas Pabst, MD, Sarah R Haile, Markus Joerger, MD, Roger von Moos, MD, Catherine Berset, Susanne Crowe, Hilde Rosing, PhD, Hermen S Overkleeft, Christiana Sessa, Marianne Kraus
Journal: Blood
Blood (2012) 120 (21): 2956.
https://doi.org/10.1182/blood.V120.21.2956.2956
Published: 2012
Journal Articles

A Multicentre Phase II Trial Testing Gemcitabine in the Treatment of Patients with Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma: SAKK 36/03.

Felicitas Hitz, MD, Giovanni Martinelli, MD, Emanuele Zucca, MD, Walter Mingrone, MD, Roger Von Moos, MD, Mathew Simcock, Jenny Peterson, Sergio Cogliatti, MD, Francesco Bertoni, MD, Michele Ghielmini, MD
Journal: Blood
Blood (2007) 110 (11): 4454.
https://doi.org/10.1182/blood.V110.11.4454.4454
Published: 2007